- $51.68m
- $26.48m
- $81.02m
- 82
- 87
- 51
- 85
Annual income statement for Vaso, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 75.5 | 69.8 | 75.6 | 79.3 | 81 |
| Cost of Revenue | |||||
| Gross Profit | 42.4 | 38.6 | 43.1 | 47.9 | 50.6 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 74.9 | 69.1 | 69.1 | 72.8 | 76.8 |
| Operating Profit | 0.591 | 0.772 | 6.46 | 6.45 | 4.2 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -0.271 | 0.357 | 6.25 | 6.55 | 4.91 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.382 | 0.358 | 6.1 | 11.3 | 4.8 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.382 | 0.358 | 6.1 | 11.3 | 4.8 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -0.382 | 0.358 | 6.1 | 11.3 | 5.27 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.002 | 0.002 | 0.015 | 0.065 | 0.03 |